For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
dc.contributor.author | Henry, Rebecca J. | |
dc.contributor.author | Kerr, Daniel M. | |
dc.contributor.author | Finn, David P. | |
dc.contributor.author | Roche, Michelle | |
dc.date.accessioned | 2020-01-13T10:54:46Z | |
dc.date.available | 2020-01-13T10:54:46Z | |
dc.date.issued | 2015-03-17 | |
dc.identifier.citation | Henry, Rebecca J., Kerr, Daniel M., Finn, David P., & Roche, Michelle. (2016). For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 64, 167-180. doi: https://doi.org/10.1016/j.pnpbp.2015.03.006 | en_IE |
dc.identifier.issn | 1878-4216 | |
dc.identifier.uri | http://hdl.handle.net/10379/15694 | |
dc.description.abstract | Toll-like receptors (TLRs) mediate the innate immune response to pathogens and are critical in the host defence, homeostasis and response to injury. However, uncontrolled and aberrant TLR activation can elicit potent effects on neurotransmission and neurodegenerative cascades and has been proposed to trigger the onset of certain neurodegenerative disorders and elicit detrimental effects on the progression and outcome of established disease. Over the past decade, there has been increasing evidence demonstrating that the endocannabinoid system can elicit potent modulatory effects on inflammatory processes, with clinical and preclinical evidence demonstrating beneficial effects on disease severity and symptoms in several inflammatory conditions. This review examines the evidence supporting a modulatory effect of endocannabinoids on TLR-mediated immune responses both peripherally and centrally, and the implications for psychiatric disorders such as depression and schizophrenia. (C) 2015 Elsevier Inc. All rights reserved. | en_IE |
dc.description.sponsorship | The authors would like to gratefully acknowledge funding received from the Science Foundation Ireland Research Frontiers Programme (Grant no. 11/RFP/NES/3175). The authors declare no conflict of interest. | en_IE |
dc.format | application/pdf | en_IE |
dc.language.iso | en | en_IE |
dc.publisher | Elsevier | en_IE |
dc.relation.ispartof | Progress In Neuro-Psychopharmacology & Biological Psychiatry | en |
dc.subject | 2-AG | en_IE |
dc.subject | Anandamide | en_IE |
dc.subject | Depression | en_IE |
dc.subject | LPS | en_IE |
dc.subject | Poly I:C | en_IE |
dc.subject | Schizophrenia | en_IE |
dc.subject | CANNABINOID CB2 RECEPTORS | en_IE |
dc.subject | MURINE ENCEPHALOMYELITIS VIRUS | en_IE |
dc.subject | INDUCED SICKNESS BEHAVIOR | en_IE |
dc.subject | MESSENGER-RNA EXPRESSION | en_IE |
dc.subject | N-ARACHIDONOYL DOPAMINE | en_IE |
dc.subject | ANXIETY-LIKE BEHAVIORS | en_IE |
dc.subject | RAT MICROGLIAL CELLS | en_IE |
dc.subject | NITRIC-OXIDE | en_IE |
dc.subject | THEILERS VIRUS | en_IE |
dc.subject | TNF-ALPHA | en_IE |
dc.title | For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders | en_IE |
dc.type | Article | en_IE |
dc.date.updated | 2020-01-10T10:22:45Z | |
dc.identifier.doi | 10.1016/j.pnpbp.2015.03.006 | |
dc.local.publishedsource | https://doi.org/10.1016/j.pnpbp.2015.03.006 | en_IE |
dc.description.peer-reviewed | peer-reviewed | |
dc.contributor.funder | Science Foundation Ireland | en_IE |
dc.internal.rssid | 9874508 | |
dc.local.contact | Michelle Roche, Physiology, Rm2002 Human Biology Building, National University Of Ireland G, University Road. 5427 Email: michelle.roche@nuigalway.ie | |
dc.local.copyrightchecked | Yes | |
dc.local.version | ACCEPTED | |
dcterms.project | info:eu-repo/grantAgreement/SFI/SFI Research Frontiers Programme (RFP)/11/RFP.1/NES/3175/IE/Endocannabinoid regulation of neuroinflammatory responses following bacterial and viral infection/ | en_IE |
nui.item.downloads | 194 |
Files in this item
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.
The following license files are associated with this item: